Subjects: Naloxone -- supply & distribution - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Naloxone -- supply & distribution

1. Exemption and exclusion from certain requirements of the Drug Supply Chain Security Act for the distribution of FDA-approved naloxone products during the opioid public health emergency: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, September 2022
Subject(s):: Government Regulation
Legislation, Drug
Naloxone -- supply & distribution
Opioid Epidemic -- prevention & control
United States
United States. Food and Drug Administration

2. Medicare Part D beneficiaries at serious risk of opioid misuse or overdose: a closer look

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2020
Subject(s):: Government Regulation
Medicare Part D -- legislation & jurisprudence
Naloxone -- supply & distribution
Opioid-Related Disorders -- prevention & control
United States
United States. Department of Health and Human Services

3. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):: Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

4. Expanding access to naloxone: a review of distribution strategies

Author(s):: Weiner, Janet, author
Murphy, Sean, author
Behrends, Czarina, author
Publication:: Philadelphia, PA : Leonard Davis Institute of Health Economics, May 2019
Subject(s):: Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Services Accessibility
Naloxone -- supply & distribution
Naloxone -- therapeutic use
Opioid-Related Disorders -- drug therapy
United States